Supplementary Figure 1 from Impact of Prior Bevacizumab Treatment on VEGF-A and PlGF Levels and Outcome Following Second-Line Aflibercept Treatment: Biomarker <i>Post Hoc</i> Analysis of the VELOUR Trial
crossref（2023）
摘要
Supp Figure 1. Longitudinal analysis of (A) VEGF-A and (B) PlGF.
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要